Bank Of America Corp Wave Life Sciences Ltd. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Bank Of America Corp holds 75,073 shares of WVE stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

75,073

Previous 93,486 19.7%

Holding current value

$1.04 Million

Previous $576,000 35.07%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.38 - $6.48 $80,648 - $119,316	-18,413 Reduced 19.7%	75,073 $374,000
Q1 2024 May 15, 2024	BUY	$3.54 - $6.84 $110,660 - $213,818	31,260 Added 50.24%	93,486 $576,000
Q4 2023 Feb 14, 2024	BUY	$4.16 - $6.87 $23,146 - $38,224	5,564 Added 9.82%	62,226 $314,000
Q2 2023 Aug 14, 2023	SELL	$3.51 - $4.69 $1.82 Million - $2.43 Million	-518,716 Reduced 90.15%	56,662 $206,000
Q1 2023 May 12, 2023	BUY	$3.58 - $6.3 $1.83 Million - $3.22 Million	510,320 Added 784.41%	575,378 $2.49 Million
Q4 2022 Feb 10, 2023	BUY	$3.18 - $7.0 $110,005 - $242,151	34,593 Added 113.55%	65,058 $455,000
Q3 2022 Nov 14, 2022	BUY	$2.37 - $4.28 $21,870 - $39,495	9,228 Added 43.45%	30,465 $110,000
Q2 2022 Aug 12, 2022	BUY	$1.23 - $3.25 $11,450 - $30,254	9,309 Added 78.04%	21,237 $69,000
Q1 2022 May 16, 2022	SELL	$2.0 - $3.28 $22,132 - $36,296	-11,066 Reduced 48.13%	11,928 $24,000
Q4 2021 Feb 08, 2022	BUY	$3.14 - $5.15 $7,843 - $12,864	2,498 Added 12.19%	22,994 $73,000
Q3 2021 Nov 15, 2021	BUY	$4.89 - $7.12 $16,772 - $24,421	3,430 Added 20.1%	20,496 $100,000
Q2 2021 Sep 13, 2021	BUY	$5.65 - $7.47 $96,422 - $127,483	17,066 New	17,066 $114,000

Others Institutions Holding WVE

# of Institutions

147

Shares Held

94M

Call Options Held

33K

Put Options Held

57.2K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.2B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Wave Life Sciences Ltd. Transaction History